19 results on '"Barral-Netto, Manoel"'
Search Results
2. CD4+CD25+ T Cells in Skin Lesions of Patients with Cutaneous Leishmaniasis Exhibit Phenotypic and Functional Characteristics of Natural Regulatory T Cells
- Author
-
Campanelli, Ana P., Roselino, Ana M., Cavassani, Karen A., Pereira, Marcelo S. F., Mortara, Renato A., Brodskyn, Claudia I., Gonçalves, Heitor S., Belkaid, Yasmine, Barral-Netto, Manoel, Barral, Aldina, and Silva, João S.
- Published
- 2006
3. Human T-Cell Responses in Leishmania Infections
- Author
-
Russo, Donna M., Barral-Netto, Manoel, Barral, Aldina, Reed, Steven G., and Sun, Tsieh, editor
- Published
- 1993
- Full Text
- View/download PDF
4. A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.
- Author
-
Machado, Paulo R L, Prates, Fernanda V O, Boaventura, Viviane, Lago, Tainã, Guimarães, Luiz H, Schriefer, Albert, Corte, Temis W F, Penna, Gerson, Barral, Aldina, Barral-Netto, Manoel, and Carvalho, Edgar M
- Subjects
GRANULOCYTE-macrophage colony-stimulating factor ,DRUG efficacy ,LEISHMANIASIS ,CONFIDENCE intervals ,LOG-rank test ,LEISHMANIA ,FISHER exact test ,TREATMENT effectiveness ,RANDOMIZED controlled trials ,T-test (Statistics) ,DESCRIPTIVE statistics ,DATA analysis software - Abstract
Background The treatment of cutaneous leishmaniasis (CL) in Brazil using pentavalent antimony (Sbv) is associated with a high rate of failure. Miltefosine has proven efficacy for CL caused by L. braziliensis, with a cure rate (CR) of 75%. A combined treatment with granulocyte macrophage colony-stimulating factor (GM-CSF) and miltefosine could increase CR and decrease healing time. Methods A randomized, double-blind clinical trial to evaluate the efficacy of miltefosine combined with topical GM-CSF (M + GM) vs miltefosine and placebo (M + P) vs Sbv in 133 patients with CL caused by L. braziliensis in Bahia, Brazil. Results The final CR at 180 days after the initiation of treatment was 44.4% in the Sbv group, 76.6% in the M + P group (P =.003 vs Sbv), and 75.6% in the M + GM group (P =.004 vs Sbv). The median healing time for cure was 102 days for the Sbv group and 60 days for both miltefosine groups (P =.0009). During the 6-month follow-up period, 4 relapses were documented: 1 in the Sbv group, 1 in the M + P group, and 2 in the M + GM group. Mild adverse events occurred in 65% of patients from the Sbv group, 76% and 79% from the M + P and M + GM groups respectively. Conclusions Miltefosine is more effective than Sbv for the treatment of CL caused by L. braziliensis in Brazil and accelerates the healing time. Association with GM-CSF does not improve therapeutic outcome. Clinical Trials Registration NCT03023111. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis.
- Author
-
Peixoto, Fábio, Nascimento, Maurício T., Costa, Rúbia, Silva, Juliana, Renard, Gaby, Guimarães, Luiz Henrique, Penna, Gerson, Barral-Netto, Manoel, Carvalho, Lucas P., Machado, Paulo R. L., and Carvalho, Edgar M.
- Subjects
CUTANEOUS leishmaniasis ,IMMUNE response ,INFLAMMATION ,T cells ,CELL culture - Abstract
Cutaneous leishmaniasis (CL) due to L. braziliensis is associated with an exaggerated inflammatory response and tissue damage. Miltefosine is more effective than pentavalent antimony (Sbv) in the treatment of CL, and here, we evaluate the ability of Sbv, miltefosine, and GM-CSF administered intravenously, orally, or topically, respectively, to modify the immune response. Patients were treated with miltefosine plus GM-CSF, miltefosine plus placebo, or Sbv. Mononuclear cells were stimulated with soluble Leishmania antigen (SLA) on day 0 and day 15 of therapy, and cytokine levels were determined in supernatants by ELISA. The lymphocyte proliferation and oxidative burst were evaluated by flow cytometry, and the degree of infection and Leishmania killing by optical microscopy. Proliferation of CD4+ T cells were enhanced in patients using miltefosine and in CD8+ T cells when GM-CSF was associated. Enhancement in the oxidative burst occurred in the miltefosine plus GM-CSF group on day 15 of therapy. Moreover, the number of L. braziliensis in infected monocytes on day 15 as well as the percentage of infected cells was lower after 48- and 72-hour culture in cells from patients treated with miltefosine plus GM-CSF. In addition to the ability of miltefosine to kill Leishmania, the changes in the immune response caused by miltefosine and GM-CSF may increase the cure rate of CL patients using these drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Human Immunology
- Author
-
Campanelli, Ana Paula, Brodskyn, Claudia Ida, Boaventura, Viviane Sampaio, Silva, Claire, Barral-Netto, Manoel, and Barral, Aldina Maria Prado
- Subjects
Inflammation ,Cutaneous leishmaniasis ,Chemokines - Abstract
Texto completo: acesso restrito. p.1220–1227 Submitted by Suelen Reis (suziy.ellen@gmail.com) on 2013-06-25T15:44:31Z No. of bitstreams: 1 1-s2.0-S0198885910004957-main.pdf: 1450332 bytes, checksum: f6a5e82e70e45252fca6bcd4b5ef0cae (MD5) Approved for entry into archive by Alda Lima da Silva(sivalda@ufba.br) on 2013-06-27T21:02:35Z (GMT) No. of bitstreams: 1 1-s2.0-S0198885910004957-main.pdf: 1450332 bytes, checksum: f6a5e82e70e45252fca6bcd4b5ef0cae (MD5) Made available in DSpace on 2013-06-27T21:02:35Z (GMT). No. of bitstreams: 1 1-s2.0-S0198885910004957-main.pdf: 1450332 bytes, checksum: f6a5e82e70e45252fca6bcd4b5ef0cae (MD5) Previous issue date: 2010 Cutaneous leishmaniasis (CL) includes different clinical manifestations displaying diverse intensities of dermal inflammatory infiltrate. Diffuse CL (DCL) cases are hyporesponsive, and lesions show very few lymphocytes and a predominance of macrophages. In contrast, localized CL (LCL) cases are responsive to leishmanial antigen, and lesions exhibit granulocytes and mononuclear cell infiltration in the early phases, changing to a pattern with numerous lymphocytes and macrophages later in the lesion. Therefore, different chemokines may affect the predominance of cell infiltration in distinct clinical manifestations. In lesions from LCL patients, we examined by flow cytometry the presence of different chemokines and their receptors in T cells, and we verified a higher expression of CXCR3 in the early stages of LCL (less than 30 days of infection) and a higher expression of CCR4 in the late stages of disease (more than 60 days of infection). We also observed a higher frequency of T cells producing IL-10 in the late stage of LCL. Using immunohistochemistry, we observed a higher expression of CCL7, CCL17 in lesions from late LCL, as well as CCR4 suggesting a preferential recruitment of regulatory T cells in the late LCL. Comparing lesions from LCL and DCL patients, we observed a higher frequency of CCL7 in DCL lesions. These results point out the importance of the chemokines, defining the different types of cells recruited to the site of the infection, which could be related to the outcome of infection as well as the clinical form observed.
- Published
- 2010
- Full Text
- View/download PDF
7. Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis.
- Author
-
Carneiro, Marcia W., Fukutani, Kiyoshi F., Andrade, Bruno B., Curvelo, Rebecca P., Cristal, Juqueline R., Carvalho, Augusto M., Barral, Aldina, Van Weyenbergh, Johan, Barral-Netto, Manoel, and de Oliveira, Camila I.
- Subjects
CUTANEOUS leishmaniasis ,GENE expression ,BLOOD cells ,RNA ,INFECTION - Abstract
Background: The initial response to Leishmania parasites is essential in determining disease development or resistance. In vitro, a divergent response to Leishmania, characterized by high or low IFN-γ production has been described as a potential tool to predict both vaccine response and disease susceptibility in vivo. Methods and findings: We identified uninfected and healthy individuals that were shown to be either high- or low IFN-γ producers (HPs and LPs, respectively) following stimulation of peripheral blood cells with Leishmania braziliensis. Following stimulation, RNA was processed for gene expression analysis using immune gene arrays. Both HPs and LPs were shown to upregulate the expression of CXCL10, IFI27, IL6 and LTA. Genes expressed in HPs only (CCL7, IL8, IFI44L and IL1B) were associated with pathways related to IL17 and TREM 1 signaling. In LPs, uniquely expressed genes (for example IL9, IFI44, IFIT1 and IL2RA) were associated with pathways related to pattern recognition receptors and interferon signaling. We then investigated whether the unique gene expression profiles described here could be recapitulated in vivo, in individuals with active Cutaneous Leishmaniasis or with subclinical infection. Indeed, using a set of six genes (TLR2, JAK2, IFI27, IFIT1, IRF1 and IL6) modulated in HPs and LPs, we could successfully discriminate these two clinical groups. Finally, we demonstrate that these six genes are significantly overexpressed in CL lesions. Conclusion: Upon interrogation of the peripheral response of naive individuals with diverging IFN-γ production to L. braziliensis, we identified differences in the innate response to the parasite that are recapitulated in vivo and that discriminate CL patients from individuals presenting a subclinical infection. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
8. Experimental Parasitology
- Author
-
Bomfim, Glória, Nascimento, Cristiane Santos, Costa, Jackson, Carvalho Filho, Edgar Marcelino de, Barral-Netto, Manoel, and Barral, Aldina Maria Prado
- Subjects
DCL ,therapy ,interleukin ,polymerase chain reaction ,PBMC ,diffuse cutaneous leishmaniasis ,IL ,peripheral blood mononuclear cells ,DEPC ,cytokines ,cutaneous leishmaniasis ,PCR ,diethylpyrocarbonate ,interferon-gamma ,leishmaniasis ,IFN-γ - Abstract
Texto completo: acesso restrito. p.188–194 Submitted by Suelen Reis (suelen_suzane@hotmail.com) on 2013-02-04T16:53:54Z No. of bitstreams: 1 Bomfim.pdf: 147739 bytes, checksum: 7a9c7f1812f8d06b2f66ec0e831c8fdf (MD5) Approved for entry into archive by Fatima Cleômenis Botelho Maria (botelho@ufba.br) on 2013-02-06T13:47:54Z (GMT) No. of bitstreams: 1 Bomfim.pdf: 147739 bytes, checksum: 7a9c7f1812f8d06b2f66ec0e831c8fdf (MD5) Made available in DSpace on 2013-02-06T13:47:54Z (GMT). No. of bitstreams: 1 Bomfim.pdf: 147739 bytes, checksum: 7a9c7f1812f8d06b2f66ec0e831c8fdf (MD5) Previous issue date: 1996 Diffuse cutaneous leishmaniasis is a rare entity characterized by disseminated cutaneous nodules associated with specific anergy to leishmanial antigens. A low but not absent IFN-γ expression by cells present in cutaneous lesions has been documented during the active phase of diffuse cutaneous leishmaniasis. In this study we confirm this observation, and extend it by showing a similar pattern in peripheral blood mononuclear cells and the variation of mRNA cytokine expression pattern during different stages of the disease. During active disease, patients did not express mRNA for IFN-γ, while expressing mRNA for IL-2, IL-4, and IL-10. In contrast, an expression of IFN-γ and low IL-10 was observed after treatment-induced transient healing of cutaneous lesions. In three patients we have been able to analyze a third PBMC sample obtained after clinical relapse, documenting in all of them decreased IFN-γ expression with no expression of IL-10. Although there was an association between the appearance of IFN-γ expression and clinical improvement, with marked expression of IFN-γ mRNA and decreased expression of mRNA for IL-10 after treatment, this was not sufficient to prevent relapse in these patients. Therefore, it is possible that factors other than the cytokines characteristic of the Th1 and Th2 balance are implicated in the inability of diffuse cutaneous leishmaniasis patients to mount an anti-Leishmaniaimmune response causing clinical improvement.
- Published
- 1996
- Full Text
- View/download PDF
9. Vaccination with Leishmania infantum Acidic Ribosomal P0 but Not with Nucleosomal Histones Proteins Controls Leishmania infantum Infection in Hamsters.
- Author
-
Pereira, Lais, Abbehusen, Melissa, Teixeira, Clarissa, Cunha, Jurema, Nascimento, Ivan P., Fukutani, Kyioshi, dos-Santos, Washington, Barral, Aldina, de Oliveira, Camila Indiani, Barral-Netto, Manoel, Soto, Manoel, and Brodskyn, Cláudia Ida
- Subjects
LEISHMANIA infantum ,HAMSTERS ,VISCERAL leishmaniasis ,HISTONES ,CUTANEOUS leishmaniasis ,HUMORAL immunity - Abstract
Background: Several intracellular Leishmania antigens have been identified in order to find a potential vaccine capable of conferring long lasting protection against Leishmania infection. Histones and Acid Ribosomal proteins are already known to induce an effective immune response and have successfully been tested in the cutaneous leishmaniasis mouse model. Here, we investigate the protective ability of L. infantum nucleosomal histones (HIS) and ribosomal acidic protein P0 (LiP0) against L. infantum infection in the hamster model of visceral leishmaniasis using two different strategies: homologous (plasmid DNA only) or heterologous immunization (plasmid DNA plus recombinant protein and adjuvant). Methodology/Principal Findings: Immunization with both antigens using the heterologous strategy presented a high antibody production level while the homologous strategy immunized group showed predominantly a cellular immune response with parasite load reduction. The pcDNA-LiP0 immunized group showed increased expression ratio of IFN-γ/IL-10 and IFN-γ/TGF-β in the lymph nodes before challenge. Two months after infection hamsters immunized with the empty plasmid presented a pro-inflammatory immune response in the early stages of infection with increased expression ratio of IFN-γ/IL-10 and IFN-γ/TGF-β, whereas hamsters immunized with pcDNA-HIS presented an increase only in the ratio IFN-γ/ TGF-β. On the other hand, hamsters immunized with LiP0 did not present any increase in the IFN-γ/TGF-β and IFN-γ/IL-10 ratio independently of the immunization strategy used. Conversely, five months after infection, hamsters immunized with HIS maintained a pro-inflammatory immune response (ratio IFN-γ/ IL-10) while pcDNA-LiP0 immunized hamsters continued showing a balanced cytokine profile of pro and anti-inflammatory cytokines. Moreover we observed a significant reduction in parasite load in the spleen, liver and lymph node in this group compared with controls. Conclusions/Significance: Our results suggest that vaccination with L. infantum LiP0 antigen administered in a DNA formulation could be considered a potential component in a vaccine formulation against visceral leishmaniasis. Author Summary: Visceral leishmaniasis caused by Leishmania infantum is the most severe form of leishmaniasis. The disease is fatal if not treated and there is no vaccine available for human use. In the search for potential antigens, the protective ability of conserved parasite protein families such as L. infantum histones (HIS) and acidic ribosomal (LiP0) antigens were successfully tested in the mouse model of cutaneous leishmaniasis. Here, we evaluate HIS and LiP0 antigens using two different immunization strategies in the hamster model of visceral leishmaniasis. Hamsters are highly susceptible to L. infantum infection and we demonstrate that immunization with LiP0, but not HIS, protects against the fatal outcome of visceral leishmaniasis. Immunization with LiP0 was able to induce an increased expression of IFN-γ in detriment of IL-10 and TGF-β in the draining lymph node before infection creating an inhospitable environment for parasite growth. Following challenge, a reduced parasite load in the lymph node, spleen and liver of LiP0 immunized hamsters was detected five months after challenge. These findings suggest that LiP0 used in a DNA formulation could be considered a potential component in a vaccine formulation against visceral leishmaniasis. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. Functional Transcriptomics of Wild-Caught Lutzomyia intermedia Salivary Glands: Identification of a Protective Salivary Protein against Leishmania braziliensis Infection.
- Author
-
de Moura, Tatiana R., Oliveira, Fabiano, Carneiro, Marcia W., Miranda, José Carlos, Clarêncio, Jorge, Barral-Netto, Manoel, Brodskyn, Cláudia, Barral, Aldina, Ribeiro, José M. C., Valenzuela, Jesus G., and de Oliveira, Camila I.
- Subjects
SALIVARY proteins ,SALIVARY glands ,LUTZOMYIA ,TRANSCRIPTOMES ,LEISHMANIA mexicana ,CUTANEOUS leishmaniasis - Abstract
Background: Leishmania parasites are transmitted in the presence of sand fly saliva. Together with the parasite, the sand fly injects salivary components that change the environment at the feeding site. Mice immunized with Phlebotomus papatasi salivary gland (SG) homogenate are protected against Leishmania major infection, while immunity to Lutzomyia intermedia SG homogenate exacerbated experimental Leishmania braziliensis infection. In humans, antibodies to Lu. intermedia saliva are associated with risk of acquiring L. braziliensis infection. Despite these important findings, there is no information regarding the repertoire of Lu. intermedia salivary proteins. Methods and Findings: A cDNA library from the Salivary Glands (SGs) of wild-caught Lu. intermedia was constructed, sequenced, and complemented by a proteomic approach based on 1D SDS PAGE and mass/mass spectrometry to validate the transcripts present in this cDNA library. We identified the most abundant transcripts and proteins reported in other sand fly species as well as novel proteins such as neurotoxin-like proteins, peptides with ML domain, and three small peptides found so far only in this sand fly species. DNA plasmids coding for ten selected transcripts were constructed and used to immunize BALB/c mice to study their immunogenicity. Plasmid Linb-11—coding for a 4.5-kDa protein—induced a cellular immune response and conferred protection against L. braziliensis infection. This protection correlated with a decreased parasite load and an increased frequency of IFN-γ-producing cells. Conclusions: We identified the most abundant and novel proteins present in the SGs of Lu. intermedia, a vector of cutaneous leishmaniasis in the Americas. We also show for the first time that immunity to a single salivary protein from Lu. intermedia can protect against cutaneous leishmaniasis caused by L. braziliensis. Author Summary: Sand fly saliva contains potent, biologically active proteins that allow the insect to stop host responses to acquire a blood meal. After repeated exposures, a number of these salivary proteins also induce a response in the host such as antibody production and/or cellular-mediated immunity. In animal models, these immune responses affect Leishmania infection. On one hand, immunity to Phlebotomus papatasi saliva protected animals against cutaneous leishmaniasis, while on the other hand, immunity to Lutzomyia intermedia saliva did not protect but exacerbated this disease. These differences are probably due to the types of proteins present in the saliva of these different sand fly species. The present work focused on isolation and identification of the secreted proteins present in the salivary glands of Lu. intermedia, an important vector of L. braziliensis, the agent of mucocutaneous leishmaniasis. Saliva from this sand fly contains a number of proteins not present in P. papatasi saliva and, with some exceptions; proteins that are homologous between the two species are very divergent. Furthermore, we identified one protein that, after vaccination, induced a cellular immune response able to protect mice against Leishmania braziliensis infection. This is the first evidence that a single salivary protein from Lu. intermedia can protect mice against this cutaneous leishmaniasis. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
11. Immunity to Lutzomyia intermedia Saliva Modulates the Inflammatory Environment Induced by Leishmania braziliensis.
- Author
-
de Moura, Tatiana R., Oliveira, Fabiano, Rodrigues, Gabriele C., Carneiro, Marcia W., Fukutani, Kiyoshi F., Novais, Fernanda O., Miranda, José Carlos, Barral-Netto, Manoel, Brodskyn, Claudia, Barral, Aldina, and de Oliveira, Camila I.
- Subjects
LUTZOMYIA ,SALIVA ,SAND flies ,SALIVARY proteins ,CUTANEOUS leishmaniasis ,DROOLING - Abstract
Background: During blood feeding, sand flies inject Leishmania parasites in the presence of saliva. The types and functions of cells present at the first host-parasite contact are critical to the outcome on infection and sand fly saliva has been shown to play an important role in this setting. Herein, we investigated the in vivo chemotactic effects of Lutzomyia intermedia saliva, the vector of Leishmania braziliensis, combined or not with the parasite. Methods and Findings: We tested the initial response induced by Lutzomyia intermedia salivary gland sonicate (SGS) in BALB/c mice employing the air pouch model of inflammation. L. intermedia SGS induced a rapid influx of macrophages and neutrophils. In mice that were pre-sensitized with L. intermedia saliva, injection of SGS was associated with increased neutrophil recruitment and a significant up-regulation of CXCL1, CCL2, CCL4 and TNF-α expression. Surprisingly, in mice that were pre-exposed to SGS, a combination of SGS and L. braziliensis induced a significant migration of neutrophils and an important modulation in cytokine and chemokine expression as shown by decreased CXCL10 expression and increased IL-10 expression. Conclusion: These results confirm that sand fly saliva modulates the initial host response. More importantly, pre-exposure to L. intermedia saliva significantly modifies the host's response to L. braziliensis, in terms of cellular recruitment and expression of cytokines and chemokines. This particular immune modulation may, in turn, favor parasite multiplication. Author Summary: Transmission of Leishmania parasites occurs during blood feeding, when infected female sand flies inject humans with parasites and saliva. Chemokines and cytokines are secreted proteins that regulate the initial immune responses and have the potential of attracting and activating cells. Herein, we studied the expression of such molecules and the cellular recruitment induced by salivary proteins of the Lutzomyia intermedia sand fly. Of note, Lutzomyia intermedia is the main vector of Leishmania braziliensis, a parasite species that causes cutaneous leishmaniasis, a disease associated with the development of destructive skin lesions that can be fatal if left untreated. We observed that L. intermedia salivary proteins induce a potent cellular recruitment and modify the expression profile of chemokines and cytokines in mice. More importantly, in mice previously immunized with L. intermedia saliva, the alteration in the initial inflammatory response was even more pronounced, in terms of the number of cells recruited and in terms of gene expression pattern. These findings indicate that an existing immunity to L. intermedia sand fly induces an important modulation in the initial immune response that may, in turn, promote parasite multiplication, leading to the development of cutaneous leishmaniasis. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
12. CD4+CD25+ T Cells in Skin Lesions of Patients with Cutaneous Leishmaniasis Exhibit Phenotypic and Functional Characteristics of Natural Regulatory T Cells.
- Author
-
Campanelli, Ana P., Roselino, Ana M., Cavassani, Karen A., Pereira, Marcelo S. F., Mortara, Renato A., Brodskyn, Claudia I., Gonçalves, Heitor S., Belkaid, Yasmine, Barral-Netto, Manoel, Barral, Aldina, and Silva, João S.
- Subjects
CUTANEOUS leishmaniasis ,LEISHMANIA ,MUCOCUTANEOUS leishmaniasis ,TUMOR necrosis factors ,CYTOKINES - Abstract
Endogenous regulatory T (T
reg ) cells are involved in the control of infections, including Leishmania infection in mice. Leishmania viannia braziliensis is the main etiologic agent of cutaneous leishmaniasis (CL) in Brazil, and it is also responsible for the more severe mucocutaneous form. Here, we investigated the possible involvement of Treg cells in the control of the immune response in human skin lesions caused by L. viannia braziliensis infection. We show that functional Treg cells can be found in skin lesions of patients with CL. These cells express phenotypic markers of Treg cells-such as CD25, cytotoxic T lymphocyte-associated antigen 4, Foxp3, and glucocorticoid-induced tumor necrosis factor receptor-and are able to produce large amounts of interleukin-10 and transforming growth factor-β. Furthermore, CD4+ CD25+ T cells derived from the skin lesions of 4 of 6 patients with CL significantly suppressed in vitro the phytohemagglutinin-induced proliferative T cell responses of allogeneic peripheral-blood mononuclear cells (PBMCs) from healthy control subjects at a ratio of 1 Treg cell to 10 allogeneic PBMCs. These findings suggest that functional Treg cells accumulate at sites of Leishmania infection in humans and possibly contribute to the local control of effector T cell functions. [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
13. DIFFUSE CUTANEOUS LEISHMANIASIS WITH ATYPICAL ASPECTS.
- Author
-
Bittencourt, Achiléa L., Barral, Aldina, Costa, Jackson M. L., Saldanha, Ana Cristina, Badaró, Fernando, Barral-Netto, Manoel, and Freitas, Luiz A. R.
- Subjects
CUTANEOUS leishmaniasis ,AMASTIGOTES ,TRYPANOSOMATIDAE ,IMMUNE response ,EOSINOPHILS ,MONOCLONAL antibodies - Abstract
A 16-year-old man had long-standing diffuse cutaneous leishmaniasis with the following characteristics: diffuse infiltrated lesions rich in amastigotes, absence of mucosal involvement and lack of parasite-specific cell-mediated immune response. In situ identification of Leishmania mexicana amazonensis was achieved by the use of monoclonal antibodies. Clinically, as an atypical finding there was deep and extensive ulceration in the lower limbs. Histologically, an atypical characteristic was the presence of a high number of eosinophils in the infiltrate predominantly in the ulcerated lesion. Ultrastructurally, parasitized and lysed eosinophils with dispersion of their granules were seen in the vicinity of parasitized or lysed macrophages. [ABSTRACT FROM AUTHOR]
- Published
- 1992
- Full Text
- View/download PDF
14. Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial.
- Author
-
Mendes, Luciana, Guerra, Jorge Oliveira, Costa, Bleno, Silva, Aríneia Soares da, Guerra, Maria das Graças Barbosa, Ortiz, Jéssica, Doria, Susan Smith, Silva, George Villarouco da, de Jesus, Denison Vital, Barral-Netto, Manoel, Penna, Gerson, Carvalho, Edgar M., and Machado, Paulo R.L.
- Subjects
- *
GRANULOCYTE-colony stimulating factor , *MACROPHAGE colony-stimulating factor , *CUTANEOUS leishmaniasis , *RANDOMIZED controlled trials , *CLINICAL trials , *MILTEFOSINE - Abstract
• Pentavalent antimony, the main therapy for CL has high failure rates. • Miltefosine has higher cure rates, but 25% of CL patients may present failure. • Topical GM-CSF associated with antimony increased the cure rate of CL by Leishmania braziliensis. • Miltefosine and GM-CSF did not increase the cure rate of CL by Leishmania guyanensis. To compare topical granulocyte and macrophage colony-stimulating factor (GM-CSF) and miltefosine (G + M) versus placebo and miltefosine (P + M) or parenteral meglumine antimoniate (MA) in the treatment of 150 patients with cutaneous leishmaniasis (CL) caused by Leishmania guyanensis in the Amazon. A randomized and double-blinded clinical trial. At 90 days after the initiation of therapy, the cure rates were 66%, 58%, and 52% for the groups P + M, G + M, and MA, respectively (p > 0.05). Cure rates at 180 days did not differ. Healing time was similar in the 3 groups, but faster in the MA group as compared to the G + M group (p = 0.04). Mild and transitory systemic adverse events were frequent in all groups (above 85%). Nausea (85%) and vomiting (39%) predominated in the miltefosine groups and arthralgia (51%) and myalgia (48%) in the MA group. One patient (group MA) stopped treatment after presenting with fever, exanthema, and severe arthralgia. Miltefosine did not present a higher cure rate than MA, and the association of GM-CSF did not improve the therapeutic response. Nevertheless, because of its less toxicity, easier administration, and a similar cure rate when compared with MA, miltefosine should remain as one of the main drugs for treating CL due to L. guyanensis. (Clinicaltrials.gov Identifier NCT03023111). [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Proteome Profiling of Human Cutaneous Leishmaniasis Lesion.
- Author
-
da Silva Santos, Claire, Attarha, Sanaz, Saini, Ravi Kanth, Boaventura, Viviane, Costa, Jackson, Khouri, Ricardo, Barral-Netto, Manoel, Brodskyn, Cláudia Ida, and Souchelnytskyi, Serhiy
- Subjects
- *
CUTANEOUS leishmaniasis , *PROTEOMICS , *SKIN inflammation , *IMMUNOHISTOCHEMISTRY , *GENE expression , *CANCER invasiveness , *THERAPEUTICS - Abstract
In this study, we used proteomics and biological network analysis to evaluate the potential biological processes and components present in the identified proteins of biopsies from cutaneous leishmaniasis (CL) patients infected by Leishmania braziliensis in comparison with normal skin. We identified 59 proteins differently expressed in samples from infected and normal skin. Biological network analysis employing identified proteins showed the presence of networks that may be involved in the cell death mediated by cytotoxic T lymphocytes. After immunohistochemical analyses, the expression of caspase-9, caspase-3, and granzyme B was validated in the tissue and positively correlated with the lesion size in CL patients. In conclusion, this work identified differentially expressed proteins in the inflammatory site of CL, revealed enhanced expression of caspase-9, and highlighted mechanisms associated with the progression of tissue damage observed in lesions. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
16. CD8+ Granzyme B+-Mediated Tissue Injury vs. CD4+IFNγ+-Mediated Parasite Killing in Human Cutaneous Leishmaniasis.
- Author
-
Santos, Claire da Silva, Boaventura, Viviane, Ribeiro Cardoso, Cristina, Tavares, Natalia, Lordelo, Morgana J, Noronha, Almério, Costa, Jackson, Borges, Valéria M., de Oliveira, Camila I, Van Weyenbergh, Johan, Barral, Aldina, Barral-Netto, Manoel, and Brodskyn, Cláudia Ida
- Subjects
- *
T cells , *LYMPHOCYTES , *CUTANEOUS leishmaniasis , *PROTOZOAN diseases , *ANTIGEN presenting cells - Abstract
A protective or deleterious role of CD8+T cells in human cutaneous leishmaniasis (CL) has been debated. The present report explores the participation of CD8+T cells in disease pathogenesis as well as in parasite killing. CD8+T cells accumulated in CL lesions as suggested by a higher frequency of CD8+CD45RO+T cells and CD8+CLA+T cells compared with peripheral blood mononuclear cells. Upon Leishmania braziliensis restimulation, most of the CD8+T cells from the lesion expressed cytolytic markers, CD107a and granzyme B. Granzyme B expression in CL lesions positively correlated with lesion size and percentage of TUNEL-positive cells. We also observed a significantly higher percentage of TUNEL-positive cells and granzyme B expression in the biopsies of patients showing a more intense necrotic process. Furthermore, coculture of infected macrophages and CD8+T lymphocytes resulted in the release of granzyme B, and the use of granzyme B inhibitor, as well as z-VAD, Fas:Fc, or anti-IFN-γ, had no effect upon parasite killing. However, coculture of infected macrophages with CD4+T cells strongly increased parasite killing, which was completely reversed by anti-IFN-γ. Our results reveal a dichotomy in human CL: CD8+ granzyme B+T cells mediate tissue injury, whereas CD4+IFN-γ+T cells mediate parasite killing. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
17. Hormone levels are associated with clinical markers and cytokine levels in human localized cutaneous leishmaniasis
- Author
-
Baccan, Gyselle Chrystina, Oliveira, Fabiano, Sousa, Adenilma Duranes, Cerqueira, Natali Alexandrino, Costa, Jackson Mauricio Lopes, Barral-Netto, Manoel, and Barral, Aldina
- Subjects
- *
BIOMARKERS , *CYTOKINES , *CUTANEOUS leishmaniasis , *IMMUNE response , *ESTRADIOL , *TESTOSTERONE , *NEUROENDOCRINE cells , *NEUROIMMUNOLOGY - Abstract
Abstract: Leishmaniasis is a serious health problem in several parts of the world, and localized cutaneous leishmaniasis (LCL) is the most frequent presentation of the tegumentary form of this disease cluster. Clinical presentations of leishmaniasis are influenced by both parasite and host factors, with emphasis on the host immune response. Alterations in plasma hormone levels have been described in many infections, and changes in hormone levels could be related to an imbalanced cytokine profile. In the present work, we evaluated a group of patients with LCL to determine changes in plasma hormone levels (cortisol, DHEA-S, estradiol, prolactin and testosterone) and their association with clinical markers of disease (lesion size, dose used to reach cure and time to cure) and with cytokines produced by PBMC stimulated by SLA (IFN-γ, IL-10 and TNF-α). Individuals with LCL exhibited lower plasma levels of DHEA-S, prolactin and testosterone compared with sex-matched controls, whereas levels of cortisol and estradiol were similar between patients and controls. Plasma levels of cortisol, estradiol or prolactin positively correlated with at least one clinical parameter. Cortisol and prolactin levels exhibited a negative correlation with levels of IFN-γ, whereas no correlation was observed with IL-10 or TNF-α levels. A decrease in DHEA-S levels was observed in male LCL patients when compared to male healthy controls. No other differences between the sexes were observed. Our results indicate a role for neuroendocrine regulation that restricts Th1 responses in human LCL. It is possible that, although impairing parasite killing, such neuroimmunomodulation may contribute to limiting tissue damage. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
18. Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis
- Author
-
Campanelli, Ana P., Brodskyn, Claudia I., Boaventura, Viviane, Silva, Claire, Roselino, Ana M., Costa, Jackson, Saldanha, Ana Cristina, Rodrigues de Freitas, Luiz Antônio, de Oliveira, Camila Indiani, Barral-Netto, Manoel, Silva, João S., and Barral, Aldina
- Subjects
- *
CHEMOKINES , *IMMUNOLOGY of inflammation , *CUTANEOUS leishmaniasis , *LYMPHOCYTES , *MACROPHAGES , *GRANULOCYTE antigens , *T cells - Abstract
Abstract: Cutaneous leishmaniasis (CL) includes different clinical manifestations displaying diverse intensities of dermal inflammatory infiltrate. Diffuse CL (DCL) cases are hyporesponsive, and lesions show very few lymphocytes and a predominance of macrophages. In contrast, localized CL (LCL) cases are responsive to leishmanial antigen, and lesions exhibit granulocytes and mononuclear cell infiltration in the early phases, changing to a pattern with numerous lymphocytes and macrophages later in the lesion. Therefore, different chemokines may affect the predominance of cell infiltration in distinct clinical manifestations. In lesions from LCL patients, we examined by flow cytometry the presence of different chemokines and their receptors in T cells, and we verified a higher expression of CXCR3 in the early stages of LCL (less than 30 days of infection) and a higher expression of CCR4 in the late stages of disease (more than 60 days of infection). We also observed a higher frequency of T cells producing IL-10 in the late stage of LCL. Using immunohistochemistry, we observed a higher expression of CCL7, CCL17 in lesions from late LCL, as well as CCR4 suggesting a preferential recruitment of regulatory T cells in the late LCL. Comparing lesions from LCL and DCL patients, we observed a higher frequency of CCL7 in DCL lesions. These results point out the importance of the chemokines, defining the different types of cells recruited to the site of the infection, which could be related to the outcome of infection as well as the clinical form observed. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
19. Role of costimulatory molecules in immune response of patients with cutaneous leishmaniasis
- Author
-
Favali, Cecilia, Costa, Dirceu, Afonso, Lilian, Conceição, Viviane, Rosato, Andréa, Oliveira, Fabiano, Costa, Jackson, Barral, Aldina, Barral-Netto, Manoel, and Brodskyn, Claudia Ida
- Subjects
- *
LYMPHOCYTES , *LEISHMANIASIS , *IMMUNE response , *GROWTH factors - Abstract
Abstract: T cell-mediated immunity is critical in resistance against Leishmania parasites, and T cell activation requires signals provided by costimulatory molecules. Herein we evaluated the role of costimulatory molecules on cytokine production and T cell surface molecule expression by peripheral blood mononuclear cells (PBMC) from cutaneous leishmaniasis (CL) patients. PBMC from CL patients were stimulated with soluble Leishmania antigen (SLA, 10 μg/ml), in the presence or absence of soluble CTLA4-Ig to block CD28-B7 interaction or in the presence or absence of anti-human CD40L to block CD40-CD40L interaction. Supernatants were harvested to evaluate tumor necrosis factor alpha (TNF-α), interleukin 10 (IL-10), transforming growth factor beta (TGF-β) and interferon gamma (IFN-γ) production by ELISA. Cells were harvested after 48 h of culture, stained for specific activation markers and analyzed by flow cytometry. Results show that the blockade of CD28-B7 interaction by CTLA4-Ig downmodulated IFN-γ, IL-10, and TNF-α secretion by PBMC from CL patients. No alteration was detected on either TGF-β production or the expression of CTLA44 or CD25 on CD4+ and CD8+ T cells. When the CD40-CD40L interaction was blockade using anti-CD40L, we did not observe changes in cytokine production or in surface molecule expression. The blockade of the CD28-B7 interactions by CTLA4-Ig also did not alter cytokine production in volunteers immunized against tetanus toxoid (TT). Taken together, these data suggest that the interaction of CTLA4 and CD28-B7 is a TGF-β-independent mechanism that specifically downmodulates the immune response in cutaneous leishmaniasis patients. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.